Peer Navigation for HIV Prevention
(MATCH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
U.S. epidemiological data indicates that Black women are a high-risk HIV disparity group, yet initiation of novel prevention strategies like pre-exposure prophylaxis (PrEP) among this group is stagnant. Socio-structural challenges like intimate partner violence and gendered racism can constrain PrEP access among Black women, but few implementation studies have mitigated these challenges to improve PrEP initiation. The proposed research aims to implement and assess the effectiveness, implementation, and sustainability of a multilevel intervention to increase PrEP initiation among Black women with and without intimate partner violence in Baltimore.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is peer navigation for HIV prevention safe for humans?
How is the Peer Navigation Group treatment for HIV prevention different from other treatments?
The Peer Navigation Group treatment is unique because it uses trained peers to guide and support individuals at risk of HIV, helping them access prevention services like pre-exposure prophylaxis (PrEP). This approach focuses on social support and personalized guidance, which can improve engagement in care and adherence to prevention strategies, unlike traditional medical treatments that rely solely on healthcare providers.12346
What data supports the effectiveness of the Peer Navigation Group treatment for HIV prevention?
Research shows that peer navigation programs can help people with HIV stay engaged in care and adhere to treatment by providing social support and addressing barriers like stigma. These programs have been effective in improving care engagement and treatment adherence, which are crucial for HIV prevention.24578
Who Is on the Research Team?
Tiara C. Willie, PhD, MA
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Are You a Good Fit for This Trial?
This trial is for Black women at high risk of HIV, focusing on those who have faced intimate partner violence and gendered racism. It aims to help them start using pre-exposure prophylaxis (PrEP) for HIV prevention.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive 4 weekly group sessions and 4 one-on-one sessions with a peer navigator
Control
Participants receive a single group session
Follow-up
Participants are monitored for PrEP initiation and adherence
What Are the Treatments Tested in This Trial?
Interventions
- Peer Navigation Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins Bloomberg School of Public Health
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator